Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy

Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respirator...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigoriadis, Charalampos, Tympa, Aliki, Liapis, Angelos, Hassiakos, Dimitrios, Bakas, Panagiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794618/
https://www.ncbi.nlm.nih.gov/pubmed/24175105
http://dx.doi.org/10.1155/2013/150278
_version_ 1782287231392677888
author Grigoriadis, Charalampos
Tympa, Aliki
Liapis, Angelos
Hassiakos, Dimitrios
Bakas, Panagiotis
author_facet Grigoriadis, Charalampos
Tympa, Aliki
Liapis, Angelos
Hassiakos, Dimitrios
Bakas, Panagiotis
author_sort Grigoriadis, Charalampos
collection PubMed
description Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respiratory failure, and death if left untreated. A case of alpha-methyldopa-induced autoimmune hemolytic anemia in a 36-year-old gravida 2, para 1 woman at 37(+6) weeks of gestation is reported herein along with the differential diagnostic procedure and the potential risks to the mother and the fetus.
format Online
Article
Text
id pubmed-3794618
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37946182013-10-30 Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy Grigoriadis, Charalampos Tympa, Aliki Liapis, Angelos Hassiakos, Dimitrios Bakas, Panagiotis Case Rep Obstet Gynecol Case Report Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respiratory failure, and death if left untreated. A case of alpha-methyldopa-induced autoimmune hemolytic anemia in a 36-year-old gravida 2, para 1 woman at 37(+6) weeks of gestation is reported herein along with the differential diagnostic procedure and the potential risks to the mother and the fetus. Hindawi Publishing Corporation 2013 2013-09-23 /pmc/articles/PMC3794618/ /pubmed/24175105 http://dx.doi.org/10.1155/2013/150278 Text en Copyright © 2013 Charalampos Grigoriadis et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Grigoriadis, Charalampos
Tympa, Aliki
Liapis, Angelos
Hassiakos, Dimitrios
Bakas, Panagiotis
Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title_full Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title_fullStr Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title_full_unstemmed Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title_short Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy
title_sort alpha-methyldopa-induced autoimmune hemolytic anemia in the third trimester of pregnancy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794618/
https://www.ncbi.nlm.nih.gov/pubmed/24175105
http://dx.doi.org/10.1155/2013/150278
work_keys_str_mv AT grigoriadischaralampos alphamethyldopainducedautoimmunehemolyticanemiainthethirdtrimesterofpregnancy
AT tympaaliki alphamethyldopainducedautoimmunehemolyticanemiainthethirdtrimesterofpregnancy
AT liapisangelos alphamethyldopainducedautoimmunehemolyticanemiainthethirdtrimesterofpregnancy
AT hassiakosdimitrios alphamethyldopainducedautoimmunehemolyticanemiainthethirdtrimesterofpregnancy
AT bakaspanagiotis alphamethyldopainducedautoimmunehemolyticanemiainthethirdtrimesterofpregnancy

Ejemplares similares